Zacks Research Brokers Raise Earnings Estimates for Corcept Therapeutics Incorporated (NASDAQ:CORT)

Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Investment analysts at Zacks Research raised their Q1 2024 EPS estimates for Corcept Therapeutics in a report issued on Tuesday, March 5th. Zacks Research analyst K. Das now anticipates that the biotechnology company will post earnings of $0.10 per share for the quarter, up from their previous […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Comments on ANI Pharmaceuticals, Inc.’s Q1 2024 Earnings (NASDAQ:ANIP)
Next post Commercial Vehicle Group, Inc. (NASDAQ:CVGI) Expected to Post Q1 2024 Earnings of $0.21 Per Share